Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Britt Christensen and Ralley Prentice.
Britt Christensen
Connection Strength
4.321
Ralley Prentice
  1. Managing COVID-19 in patients with inflammatory bowel disease: navigating unprecedented challenges. Intern Med J. 2021 02; 51(2):284-287.
    View in: PubMed
    Score: 0.927
  2. Letter: Covid-19-re-initiating clinical services for chronic gastrointestinal diseases. How and when? Authors' reply. Aliment Pharmacol Ther. 2020 10; 52(8):1416-1417.
    View in: PubMed
    Score: 0.906
  3. Letter: ACE2, IBD and COVID-19-why IBD patients may be at reduced risk of COVID-19. Aliment Pharmacol Ther. 2020 10; 52(8):1422-1423.
    View in: PubMed
    Score: 0.906
  4. Asymptomatic screening for SARS CoV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice. Dig Liver Dis. 2020 11; 52(11):1250-1251.
    View in: PubMed
    Score: 0.900
  5. Letter: SARS-CoV-2 infection in two inflammatory bowel disease patients treated with dual targeted therapy-Authors' reply. Aliment Pharmacol Ther. 2021 03; 53(6):766-767.
    View in: PubMed
    Score: 0.233
  6. Care of the Patient With IBD Requiring Hospitalisation During the COVID-19 Pandemic. J Crohns Colitis. 2020 12 02; 14(12):1796.
    View in: PubMed
    Score: 0.229
  7. Review article: prevention, diagnosis and management of COVID-19 in the IBD patient. Aliment Pharmacol Ther. 2020 07; 52(1):54-72.
    View in: PubMed
    Score: 0.221
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.